{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:08:35Z","timestamp":1784041715578,"version":"3.55.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cancertreatmentreviews.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ctrv.2026.103170","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:10:11Z","timestamp":1781737811000},"page":"103170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Early onset pancreatic Cancer: epidemiology, molecular features, and clinical outcomes"],"prefix":"10.1016","volume":"148","author":[{"given":"Fausto","family":"Petrelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Dottorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Celotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Meriggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Cherri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Oneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Tomasello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Ghidini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Baiocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Zaniboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ctrv.2026.103170_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"25","key":"10.1016\/j.ctrv.2026.103170_bb0010","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","article-title":"FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer","volume":"379","author":"Conroy","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103170_bb0015","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"10.1016\/j.ctrv.2026.103170_bb0020","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/jnci\/djab038","article-title":"Early-onset pancreas cancer: clinical descriptors, genomics, and outcomes","volume":"113","author":"Varghese","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"10.1016\/j.ctrv.2026.103170_bb0025","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1002\/cncr.33664","article-title":"Treatment patterns and survival in patients with early-onset pancreatic cancer","volume":"127","author":"Saadat","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2026.103170_bb0030","doi-asserted-by":"crossref","first-page":"828","DOI":"10.18632\/oncotarget.28242","article-title":"Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival","volume":"13","author":"Ulanja","year":"2022","journal-title":"Oncotarget"},{"key":"10.1016\/j.ctrv.2026.103170_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113471","article-title":"Risk factors for early-onset pancreatic ductal adenocarcinoma: a systematic literature review","volume":"198","author":"Chandana","year":"2024","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ctrv.2026.103170_bb0040","doi-asserted-by":"crossref","first-page":"976","DOI":"10.12688\/f1000research.153743.1","article-title":"The association between early-onset pancreatic ductal adenocarcinoma and patients survival: a systematic review and meta-analysis","volume":"13","author":"Renaldi","year":"2024","journal-title":"F1000Research"},{"issue":"11","key":"10.1016\/j.ctrv.2026.103170_bb0045","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/ijc.35135","article-title":"Clinical and molecular features of early onset pancreatic adenocarcinoma","volume":"155","author":"R\u00e9mond","year":"2024","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.ctrv.2026.103170_bb0050","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/1878-0261.13576","article-title":"Molecular characteristics of early-onset pancreatic ductal adenocarcinoma","volume":"18","author":"Debernardi","year":"2024","journal-title":"Mol Oncol"},{"issue":"36","key":"10.1016\/j.ctrv.2026.103170_bb0055","first-page":"3929","article-title":"Overall survival results from the POLO trial: a phase III study of active maintenance olaparib versus placebo for germline BRCA-mutated metastatic pancreatic cancer","volume":"40","author":"Hammel","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2026.103170_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.pan.2026.03.002","article-title":"Characterisation of early-onset pancreatic adenocarcinoma molecular profile compared to average-onset pancreatic adenocarcinoma (CARAPAC): a systematic review and a meta-analysis","author":"Brugel","year":"2026","journal-title":"Pancreatology"},{"issue":"4","key":"10.1016\/j.ctrv.2026.103170_bb0065","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.hpb.2025.12.026","article-title":"Clinical and molecular features of resected early onset pancreatic ductal adenocarcinoma: insights from the NCDB and cBioPortal","volume":"28","author":"Mughal","year":"2026","journal-title":"HPB"},{"issue":"13","key":"10.1016\/j.ctrv.2026.103170_bb0070","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1200\/JCO.19.02931","article-title":"Randomized, multicenter, phase II trial of gemcitabine and cisplatin with or without veliparib in patients with pancreas adenocarcinoma and a germline BRCA\/PALB2 mutation","volume":"38","author":"O\u2019Reilly","year":"2020","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103170_bb0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14740\/wjon1166","article-title":"Epidemiology of pancreatic cancer: global trends, etiology and risk factors","volume":"10","author":"Rawla","year":"2019","journal-title":"World J Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103170_bb0080","article-title":"The burden and temporal trend of early-onset pancreatic cancer based on the global burden of disease 2021 study","volume":"14","author":"Tan","year":"2025","journal-title":"Cancer Med"},{"issue":"10242","key":"10.1016\/j.ctrv.2026.103170_bb0085","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer","volume":"395","author":"Mizrahi","year":"2020","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ctrv.2026.103170_bb0090","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1053\/j.gastro.2019.02.037","article-title":"Real-time targeted genome profile analysis of pancreatic ductal adenocarcinomas identifies genetic alterations that might be targeted with existing drugs or used as biomarkers","volume":"156","author":"Singhi","year":"2019","journal-title":"Gastroenterology"},{"issue":"7592","key":"10.1016\/j.ctrv.2026.103170_bb0095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Australian pancreatic Cancer genome initiative. Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ctrv.2026.103170_bb0100","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1903387","article-title":"Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer","volume":"381","author":"Golan","year":"2019","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ctrv.2026.103170_bb0105","first-page":"441","article-title":"Resectability criteria for pancreatic cancer: review of current evidence and implications for neoadjuvant therapy","volume":"35","author":"Weniger","year":"2018","journal-title":"Dig Surg"},{"issue":"2","key":"10.1016\/j.ctrv.2026.103170_bb0110","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","article-title":"Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment","volume":"163","author":"Wood","year":"2022","journal-title":"Gastroenterology"},{"issue":"7414","key":"10.1016\/j.ctrv.2026.103170_bb0115","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ctrv.2026.103170_bb0120","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1016\/S2468-2667(18)30267-6","article-title":"Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry","volume":"4","author":"Sung","year":"2019","journal-title":"Lancet Public Health"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103170_bb0125","first-page":"31","article-title":"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States","volume":"68","author":"Islami","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"23","key":"10.1016\/j.ctrv.2026.103170_bb0130","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1001\/jama.2018.6228","article-title":"Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer","volume":"319","author":"Hu","year":"2018","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.ctrv.2026.103170_bb0135","first-page":"1220","article-title":"PRODIGE 35-PANOPTIMOX investigators. Five-year outcomes of FOLFIRINOX vs gemcitabine as first-line treatment for metastatic pancreatic cancer: a randomized clinical trial","volume":"6","author":"Conroy","year":"2020","journal-title":"JAMA Oncol"},{"issue":"Suppl. 4","key":"10.1016\/j.ctrv.2026.103170_bb0140","article-title":"NAPOLI-3: A randomized, open-label phase 3 study of liposomal irinotecan + 5-fluorouracil\/leucovorin + oxaliplatin (NALIRIFOX) versus nab-paclitaxel + gemcitabine in treatment-na\u00efve patients with metastatic pancreatic ductal adenocarcinoma (mPDAC)","volume":"41","author":"Tempero","year":"2023","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2026.103170_bb0145","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/j.gastro.2020.10.007","article-title":"Worldwide burden of, risk factors for, and trends in pancreatic cancer","volume":"160","author":"Huang","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103170_bb0150","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41467-018-02942-5","article-title":"Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer","volume":"9","author":"Klein","year":"2018","journal-title":"Nat Commun"},{"issue":"52","key":"10.1016\/j.ctrv.2026.103170_bb0155","doi-asserted-by":"crossref","first-page":"85785","DOI":"10.18632\/oncotarget.11768","article-title":"Therapy-related acute myeloid leukemia following treatment of lymphoid malignancies","volume":"7","author":"Permuth","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.ctrv.2026.103170_bb0160","first-page":"1661","article-title":"Association between body mass index and pancreatic cancer in an Asian population: a prospective cohort study","volume":"59","author":"He","year":"2020","journal-title":"Eur J Nutr"},{"issue":"22","key":"10.1016\/j.ctrv.2026.103170_bb0165","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/jnci\/90.22.1710","article-title":"Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews","volume":"90","author":"Silverman","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.ctrv.2026.103170_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072311","article-title":"An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population","volume":"8","author":"Klein","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ctrv.2026.103170_bb0175","article-title":"A contemporary review of molecular therapeutic targets for adenoid cystic carcinoma","volume":"14","author":"Petrucciani","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103170_bb0180","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12916-018-1120-9","article-title":"Stratified survival of resected and overall pancreatic cancer patients in Europe and the United States in the early twenty-first century: a large, international population-based study","volume":"16","author":"Huang","year":"2018","journal-title":"BMC Med"},{"issue":"3","key":"10.1016\/j.ctrv.2026.103170_bb0185","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","article-title":"Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"8","year":"2022","journal-title":"JAMA Oncol"},{"issue":"10","key":"10.1016\/j.ctrv.2026.103170_bb0190","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1101\/gad.1415606","article-title":"Genetics and biology of pancreatic ductal adenocarcinoma","volume":"20","author":"Hezel","year":"2006","journal-title":"Genes Dev"},{"key":"10.1016\/j.ctrv.2026.103170_bb0195","doi-asserted-by":"crossref","DOI":"10.1007\/s00423-019-01810-0","article-title":"Early-onset pancreatic cancer: a population-based study using the SEER registry","author":"Ansari","year":"2019","journal-title":"Langenbeck\u2019s Arch Surg"},{"key":"10.1016\/j.ctrv.2026.103170_bb0200","doi-asserted-by":"crossref","DOI":"10.1158\/1940-6207.CAPR-18-0014","article-title":"High prevalence of hereditary cancer syndromes and outcomes in adults with early-onset pancreatic cancer","author":"Bannon","year":"2018","journal-title":"Cancer Prev Res (Phila)"},{"issue":"3","key":"10.1016\/j.ctrv.2026.103170_bb0205","doi-asserted-by":"crossref","first-page":"405","DOI":"10.21614\/chirurgia.113.3.405","article-title":"Very early onset pancreatic adenocarcinoma: clinical presentation, risk factors and therapeutic options","volume":"113","author":"Bunduc","year":"2018","journal-title":"Chirurgia (Bucur)"},{"key":"10.1016\/j.ctrv.2026.103170_bb0210","doi-asserted-by":"crossref","DOI":"10.1097\/MPA.0000000000002331","article-title":"The global burden of early-onset pancreatic cancer and its risk factors","author":"Danpanichkul","year":"2024","journal-title":"Pancreas"},{"key":"10.1016\/j.ctrv.2026.103170_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.30273","article-title":"Early onset pancreatic malignancies: clinical characteristics and survival associations","author":"Beeghly-Fadiel","year":"2016","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.ctrv.2026.103170_bb0220","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3390\/cancers14020283","article-title":"Trends in the incidence and treatment of early-onset pancreatic cancer","volume":"14","author":"Gaddam","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctrv.2026.103170_bb0225","doi-asserted-by":"crossref","DOI":"10.1007\/s00428-011-1056-3","article-title":"Precursor lesions of early onset pancreatic cancer","author":"Liszka","year":"2011","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ctrv.2026.103170_bb0230","article-title":"Risk factors for early-onset and very-early-onset pancreatic adenocarcinoma","author":"RR","year":"2016","journal-title":"Pancreas"},{"key":"10.1016\/j.ctrv.2026.103170_bb0235","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-018-0866-z","article-title":"Demographic, clinical, and pathological features of early onset pancreatic cancer patients","author":"Ntala","year":"2018","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.ctrv.2026.103170_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.pan.2015.01.013","article-title":"Early onset pancreatic cancer: risk factors, presentation and outcome","author":"Piciucchi","year":"2015","journal-title":"Pancreatology"},{"key":"10.1016\/j.ctrv.2026.103170_bb0245","article-title":"Real-time identification of pancreatic cancer cases using artificial intelligence developed on Danish nationwide registry data","author":"Placido","year":"2023","journal-title":"JCO Clin Cancer Inform"},{"key":"10.1016\/j.ctrv.2026.103170_bb0250","doi-asserted-by":"crossref","DOI":"10.1158\/1055-9965.EPI-07-0341","article-title":"Early onset pancreatic cancer: evidence of a major role for smoking and genetic factors","author":"Raimondi","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ctrv.2026.103170_bb0255","article-title":"Age is in the eye of the beholder: distinguishing molecular signatures in early-onset pancreatic adenocarcinomas","author":"Tsang","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103170_bb0260","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/gutjnl-2019-319352","article-title":"Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the international Cancer of the pancreas screening (CAPS) Consortium","volume":"69","author":"Goggins","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.ctrv.2026.103170_bb0265","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1038\/s41591-023-02640-w","article-title":"Large-scale pancreatic cancer detection via non-contrast CT and deep learning","volume":"29","author":"Cao","year":"2023","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103170_bb0270","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1148\/radiol.220152","article-title":"Pancreatic cancer detection on CT scans with deep learning: a nationwide population-based study","volume":"306","author":"Chen","year":"2023","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.ctrv.2026.103170_bb0275","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1053\/j.gastro.2023.08.034","article-title":"Automated artificial intelligence model trained on a large data set can detect pancreas cancer on diagnostic computed tomography scans as well as visually occult preinvasive cancer on prediagnostic computed tomography scans","volume":"165","author":"Korfiatis","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ctrv.2026.103170_bb0280","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2025-337266","article-title":"Next-generation AI for visually occult pancreatic cancer detection in a low-prevalence setting with longitudinal stability and multi-institutional generalisability","author":"Mukherjee","year":"2026","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.ctrv.2026.103170_bb0285","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41591-023-02332-5","article-title":"A deep learning algorithm to predict risk of pancreatic cancer from disease trajectories","volume":"29","author":"Placido","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.ctrv.2026.103170_bb0290","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1191008","article-title":"Diagnostic value of deep learning-assisted endoscopic ultrasound for pancreatic tumors: a systematic review and meta-analysis","volume":"13","author":"Lv","year":"2023","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2026.103170_bb0295","article-title":"Diagnostic value of artificial intelligence-assisted endoscopic ultrasound for pancreatic cancer: a systematic review and meta-analysis","volume":"12","author":"Dumitrescu","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"6378","key":"10.1016\/j.ctrv.2026.103170_bb0300","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.aar3247","article-title":"Detection and localization of surgically resectable cancers with a multi-analyte blood test","volume":"359","author":"Cohen","year":"2018","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.ctrv.2026.103170_bb0305","doi-asserted-by":"crossref","first-page":"7459","DOI":"10.1007\/s13277-014-1995-9","article-title":"Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a meta-analysis","volume":"35","author":"Huang","year":"2014","journal-title":"Tumour Biol"},{"issue":"6378","key":"10.1016\/j.ctrv.2026.103170_bb0310","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.aar3247","article-title":"Detection and localization of surgically resectable cancers with a multi-analyte blood test","volume":"359","author":"cfDNA \/ CancerSEEK liquid biopsy context","year":"2018","journal-title":"Science"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737226000848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737226000848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:45:43Z","timestamp":1784040343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737226000848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":62,"alternative-id":["S0305737226000848"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2026.103170","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early onset pancreatic Cancer: epidemiology, molecular features, and clinical outcomes","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2026.103170","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103170"}}